Molecular origins of APOBEC-associated mutations in cancer

DNA Repair (Amst). 2020 Oct:94:102905. doi: 10.1016/j.dnarep.2020.102905. Epub 2020 Jul 6.

Abstract

The APOBEC family of cytidine deaminases has been proposed to represent a major enzymatic source of mutations in cancer. Here, we summarize available evidence that links APOBEC deaminases to cancer mutagenesis. We also highlight newly identified human cell models of APOBEC mutagenesis, including cancer cell lines with suspected endogenous APOBEC activity and a cell system of telomere crisis-associated mutations. Finally, we draw on recent data to propose potential causes of APOBEC misregulation in cancer, including the instigating factors, the relevant mutator(s), and the mechanisms underlying generation of the genome-dispersed and clustered APOBEC-induced mutations.

Keywords: APOBEC mutations; Cancer cell lines; Cancer mutagenesis; Chromothripsis; Kataegis; Mutational signature.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • APOBEC Deaminases / genetics*
  • Animals
  • Humans
  • Mutagenesis
  • Mutation*
  • Neoplasms / enzymology*
  • Neoplasms / genetics

Substances

  • APOBEC Deaminases